Chondrosarcoma of the iliac wing in Von Hippel-Lindau disease

Journal of Experimental and Clinical Cancer Research

Volumn 26, Issue 4, 2007, Pages 599-601

  Marinozzi, A ^a   Papapietro, N ^a   Barnaba, S A ^a   Di Martino, A ^a   Tonini, G ^a   Denaro, Vincenzo ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Chondrosarcoma; Quality of life; Von Hipple Lindau

Indexed keywords

PHENOL;

ADULT; AMPUTATION; ANGIOGRAPHY; ARTICLE; ARTIFICIAL EMBOLISM; BONE ALLOGRAFT; BONE ATROPHY; BONE BIOPSY; BONE METASTASIS; BONE REMODELING; BONE SCINTISCANNING; CANCER SURGERY; CASE REPORT; CHONDROSARCOMA; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; GENETIC DISORDER; HEMIPELVECTOMY; HUMAN; ILIAC CREST; KIDNEY INJURY; LIFE EXPECTANCY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CARCINOMA; PANCREAS RESECTION; PATHOLOGY; PELVIS; PLATE FIXATION; PRIORITY JOURNAL; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; VON HIPPEL LINDAU DISEASE;

ADULT; BONE NEOPLASMS; CHONDROSARCOMA; HUMANS; ILIUM; MALE; PELVIC BONES; QUALITY OF LIFE; VON HIPPEL-LINDAU DISEASE;

EID: 38549096064     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. D'hondt R., Thomas J., Van Oosterom A.T., Dewolf-Peeters C.: Hodgkin's disease in a patient with Von Hippel-Lindau disease. A case report. Acta Clin. Belg. 55:276-278, 2000.
2. Martin R., Hockey A., Walpole I., Goldblatt J.: Variable penetrance of familial pheochromocytoma associated with the von Hipple Lindau gene mutation, S68W. Mutations in brief no. 150. J. Hum Mutat.12:71, 1998.
3. Decker H.J., Weidt E..J, Brieger J.: The von Hippel-Lindau tumor suppressor gene. A rare and intriguing disease opening new insight into basic mechanisms of carcinogenesis. J. Cancer Genet. Cytogenet. 93:74-83, 1997.
4. Trieb K., Bitzan P., Lang S., Dominkus M., Kotz R.: Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapy. Eur. J. Surg. Oncol. 27:200-202, 2001.
5. Wessalowski R., Schneider D.T., Mils O., Hannen M., Calaminus G., Engelbrecht V., Pape H., Willers R., Engert J., Harms D., Gobel U. : An approach for cure: PEI-chemotherapy and regional deep hyperthermia in children and adolescents with unresectable malignant tumors. Klin. Padiatr. 215:303-309, 2003.
6. Aydinli U., Ozturk C., Yalcinkaya U., Tirelioglu O., Ersozlu S.: Limb-sparing surgery for primary malignant tumours of the pelvis. Acta Orthop. Belg. 70:417-422, 2004.
7. Rinas A.C., Ward W.G., Kilpatrick S.E.: Potential sampling error in fine needle aspiration biopsy of dedifferentiated chondrosarcoma: a report of 4 cases. Acta Cytol. 49:554-559, 2005.
8. Aprin H., Riseborough E.J., Hall J.E.: Chondrosarcoma in children and adolescents. Clin. Orthop. Relat. Res. 166:226-232, 1982.
9. Mahboubi S., Dormans J.P., D'Angio G.: Malignant degeneration of radiation-induced osteochondroma. Skeletal. Radiol. 26:195-198,1997.
10. Satcher Jr. R.L., O'Donnell R.J., Johnston J.O.: Reconstruction of the pelvis after resection of tumors about the acetabulum. Clin. Orthop. Relat. Res. 409:209-217, 2003.
11. Lin C., McGough R., Aswad B., Block J.A. Terek R.: Hypoxia induces HIF-1alpha and VEGF expression in chondrosarcoma cells and chondrocytes. J. Orthop. Res. 22:1175-1181, 2004.
12. Blancher C., Moore J.W., Robertson N., Harris A.L.: Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3′-kinase/Akt signaling pathway. Cancer Res. 61:7349-7355, 2001.
13. Kurban G., Hudon V., Duplan E., Ohh M., Pause A: Characterization of a von Hippel Lindau pathway involved in extracellular matrix remodeling, cell invasion, and angiogenesis. Cancer Res. 66:1313-1319, 2006
14. Levine A.M., Tulpule A., Quinn D.I., Gorospe G. 3rd., Smith D.L., Hornor L., Boswell W.D., Espina B.M., Groshen S.G., Masood R., Gill P.S.: Phase I study of antisense oligonucleotide against vascular endothelial growth factor: decrease in plasma vascular endothelial growth factor with potential clinical efficacy. J Clin. Oncol. 24:1712-1719, 2006 (Epub 2006 Mar 6)